Title : TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell.

Pub. Date : 2021

PMID : 33824865






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. Oxaliplatin tumor protein p53 Homo sapiens
2 In our experiments, we aim to elucidate the associations among TRIM29 protein, mutant P53, and the resistance of colon cancer cells to oxaliplatin. Oxaliplatin tumor protein p53 Homo sapiens
3 TRIM29 significantly increased the sensitivity of P53 mutant colon cancer cell HT29 to oxaliplatin. Oxaliplatin tumor protein p53 Homo sapiens
4 The oxaliplatin-resistant model of P53 mutant colon cancer cell HT29 was successfully constructed. Oxaliplatin tumor protein p53 Homo sapiens
5 Conclusion: In mutant P53 colon cancer cell HT29, TRIM29 greatly increased the sensitivity of HT29 to oxaliplatin and reverse oxaliplatin resistance. Oxaliplatin tumor protein p53 Homo sapiens
6 Conclusion: In mutant P53 colon cancer cell HT29, TRIM29 greatly increased the sensitivity of HT29 to oxaliplatin and reverse oxaliplatin resistance. Oxaliplatin tumor protein p53 Homo sapiens
7 The underlying mechanism is TRIM29 may increase the sensitivity of HT29 to oxaliplatin by blocking the transcriptional function of mutant P53, which inhibits the transcription function of its downstream gene such as MDR1. Oxaliplatin tumor protein p53 Homo sapiens